Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $6.67 Million - $7.86 Million
12,700 New
12,700 $7.4 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $12 Million - $14.1 Million
-43,102 Reduced 99.25%
326 $106,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $6.69 Million - $8.31 Million
28,497 Added 190.86%
43,428 $12.4 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $382,245 - $474,368
-1,700 Reduced 10.22%
14,931 $4.12 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $2.03 Million - $2.63 Million
11,254 Added 209.3%
16,631 $3.82 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $223,803 - $289,724
-1,362 Reduced 20.21%
5,377 $1.01 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $879,169 - $1.16 Million
6,739 New
6,739 $1.14 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $285,527 - $343,628
-2,093 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $15,595 - $19,302
131 Added 6.68%
2,093 $290,000
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $520,058 - $644,139
-4,864 Reduced 71.26%
1,962 $258,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $622,906 - $677,561
5,833 Added 587.41%
6,826 $763,000
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $14,845 - $17,328
134 Added 15.6%
993 $110,000
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $95,615 - $112,546
859 New
859 $111,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $3,812 - $4,271
-36 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $3,090 - $3,863
36 New
36 $4,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $7,717 - $9,110
-104 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $8,521 - $9,140
104
104 $9,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.